This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.
Actions
Dec 11, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.